Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Crizotinib (CZT) is an antitumor (cancer) drug that can be used to treat metastatic (cancer that has spread) non-small cell lung cancer (NSCLC) caused by defects in the anaplastic lymphoma kinase (ALK) gene or ROS1 gene. Crizotinib is also used to treat inflammatory myofibroblastoma (IMT) that is unresectable (cancer that cannot be surgically removed) , recurrent (cancer that keeps coming back) , or refractory (cancer that does not respond to treatment).